Dr. Rhonda Patrick and MedCram founders Dr. Roger Seheult and physician assistant Kyle Allred discuss COVID-19 vaccines.
Dr. Eric M. Verdin discusses the roles of the ketogenic diet, beta-hydroxybutyrate, HDAC inhibitors, NAD+, and more in the context of aging.
Rich Roll shares his thoughts on self-transformation, the environmental impact of food, and the benefits of eating a plant-based diet.
Decreased consumption of chlorophyll containing vegetables, decreased absorption, and increased excretion is largely the primary reasons why apprximately 45% of US population is deficient in magnesium.
Systemic inflammation is an important mechanism that research shows may have a very interesting relationship with depression.
This episode, featuring Dr. Rhonda Patrick, dives deep into the science and practicality of incorporating vigorous-intensity exercise into our lives.
Dr. Charles Raison discusses the role inflammation plays in the development of depression in response to illness and stress.
Dr. Michael Snyder discusses personalized medicine and the use of technologies that monitor metabolism and other health markers.
Dr. Patrick discusses some of the compelling evidence that suggests exercise is a tool for preventing or managing the symptoms of depression.
Research suggests psilocybin may have effects therapeutic for depression. In this episode, we discuss some of the qualities of the psychedelic experience that most lend psilocybin to be potentially therapeutically beneficial for depression.
Dr. Jari Laukkanen discusses the role of heat stress in the prevention of cardiovascular & Alzheimer’s disease.
Dr. Bruce Ames discusses his triage theory, which he proposes that the body has developed a rationing response to shortages of micronutrients (vitamins and minerals) throughout evolution.
Dr. Ruth Patterson discusses the role of fasting in the prevention and survivorship of breast cancer.
Compared to people with the lowest blood concentrations of EPA and DHA (combined), those with the highest blood concentrations were as much as 17 percent less likely to die from all causes of premature death.
Dr. Roland Griffiths discusses the effects of the psychedelic compound psilocybin on the human brain.
